Clinical Results
Measurable results for your patients.
Abnormal uterine bleeding affects one in four American women. The condition impacts every aspect of these women’s lives, from the clothes they wear to their level of physical activity and overall health. Many are not aware that their condition can be treated in the comfort of your office.
Global endometrial ablation (GEA)
The American College of Obstetricians and Gynecologists recently developed new practice guidelines recommending global endometrial ablation (GEA) therapy as a first approach to reducing bleeding for premenopausal women who:
- are done having children
- experience AUB symptoms due to benign causes
These guidelines establish "normalization of bleeding" as the treatment goal of GEA therapy.
Clinical benefits of using Her Option
Her Option lets you deliver the benefits of GEA using a method that’s convenient and comfortable for your patients, and simple to administer. Additionally, the subzero temperatures of cryoablation provide a natural analgesic effect that improves patient comfort during the procedure.
The following data were gathered from prospective, multi-center studies evaluating the safety and effectiveness of Her Option extended treatment regimens.
Her Option benefits include:
Click plus sign (+) to view details.
Reduction in Bleeding
Duleba et al. A Randomized study Comparing Endometrial Cryoablation and Rollerball Electroablation for Treatment of Dysfunctional Uterine Bleeding. Journal of the AAGL. 2003 Feb; 10(1) 17-26
Patient Satisfaction
Duleba et al. A Randomized study Comparing Endometrial Cryoablation and Rollerball Electroablation for Treatment of Dysfunctional Uterine Bleeding. Journal of the AAGL. 2003 Feb; 10(1) 17-26
Duleba et al. A Randomized study Comparing Endometrial Cryoablation and Rollerball Electroablation for Treatment of Dysfunctional Uterine Bleeding. Journal of the AAGL. 2003 Feb; 10(1) 17-26
Pain Assessment (0-10 scale) during procedure
Mean overall pain score of 1.1 (SD 1.68) corresponding to mild, annoying pain.
77% of patients received paracervical block, oral/IM analgesia, COX2 inhibitor combination only
Lukes at al, ACOG 2007
- Approximately 50% of patients with menorrhagia also complained of severe pain and mood
- Improvements seen within 3 months of treatment
- Statistically significant improvement in pain associated with menorrhagia
- Decrease from 54% "very severe to severe" at baseline to 5% at 3 months and 0 at 12 months
- Statistically significant improvement in associated complaints related to mood
- Decrease from 93% "often or sometimes experiencing mood" at baseline to 14% at 3 months and 10% at 12 months
Lukes at al, AAGL, 2006
8 out of 10 patients avoided a hysterectomy after 3 years¹
Percentage of Patients Very/Extremely Satisfied²
Percentage of Patients that Would Recommend Therapy to a Friend²
¹Reference is Data on file.
²Instructions for use.
